JMV 176
amino acid sequence given in first source; CCK agonist when first given, becomes cholecystokinin antagonist after 3-4 hours
Also Known As:
Boc-Tyr(SO3)-Nle-psi-(COCH2)-Gly-Trp-Nle-Asp-Phe-NH2; JMV-176; tert-butyloxycarbonyl-sulfo-tyrosyl-psi-acetyl-glycyl-tryptophyl-norleucyl-aspartyl-phenylalanylamide; L-Phenylalaninamide, N-(5-((2-(((1,1-dimethylethoxy)carbonyl)amino)-1-oxo-3-(4-(sulfooxy)phenyl)propyl)amino)-1,4-dioxononyl)-L-tryptophyl-L-norleucyl-L-alpha-aspartyl-, (S-(R*,R*))-
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results